Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Clinical trial NCT06957691 · RECRUITING

Trial details

NCT number: NCT06957691
Sponsor: Shehzad Basaria, M.D.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease Prostate Cancer Recurrent Prostate Carcinoma Prostate Neoplasm Prostate Adenocarcinoma Prostate Cancer With Bone Metastasis Vasomotor Disturbance Vasomotor Symptoms Vasomotor Symptoms (VMS)Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Start date: 2026-01-14
Primary completion: 2028-08-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.